Ahmet Acet Selected Research

Ahmet Acet Research Topics

Disease

12	Ischemia 08/2021 - 04/2002
9	Myocardial Ischemia (Ischemic Heart Diseases) 08/2021 - 11/2002
5	Myocardial Infarction 08/2021 - 08/2004
5	Infarction (Infarctions) 08/2021 - 11/2002
4	Reperfusion Injury 01/2007 - 07/2003
3	Acute Kidney Injury (Acute Renal Failure) 01/2006 - 10/2002
2	Necrosis 08/2021 - 01/2004
2	Inflammation (Inflammations) 10/2017 - 06/2013
2	Cardiotoxicity 04/2006 - 11/2003
1	Sleep Wake Disorders 05/2022
1	Thromboembolism 08/2021
1	Atherosclerosis 08/2021
1	Cardiogenic Shock 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Schizophrenia (Dementia Praecox) 08/2015
1	Colitis 06/2013
1	Urinary Tract Infections (Urinary Tract Infection) 12/2012
1	Renal Insufficiency (Renal Failure) 08/2007
1	Neoplasms (Cancer) 04/2006
1	Cardiomyopathies (Cardiomyopathy) 04/2006
1	Coronary Occlusion 05/2005
1	Heart Injuries 05/2005
1	Brain Ischemia (Cerebral Ischemia) 11/2004
1	Acute Coronary Syndrome 08/2004
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2002
1	Cardiac Arrhythmias (Arrythmia) 04/2002

Drug/Important Bio-Agent (IBA)

11	MelatoninIBA 06/2013 - 04/2002
7	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017 - 07/2003
5	Free RadicalsIBA 11/2007 - 04/2002
5	caffeic acid phenethyl esterIBA 01/2007 - 08/2004
4	AntioxidantsIBA 10/2017 - 05/2005
4	pimagedine (aminoguanidine)IBA 04/2006 - 09/2005
3	salicylhydroxamic acid (SHAM)IBA 01/2012 - 11/2002
2	Captopril (Capoten)FDA LinkGeneric 08/2021 - 12/2011
2	Losartan (Cozaar)FDA LinkGeneric 08/2021 - 12/2011
2	Glutathione (Reduced Glutathione)IBA 10/2006 - 05/2005
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2006 - 09/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2006 - 09/2005
2	Malondialdehyde (Propanedial)IBA 10/2006 - 05/2005
2	Oxidants (Oxidizing Agents)IBA 02/2006 - 05/2005
1	Modafinil (Provigil)FDA Link 05/2022
1	Type 2 Angiotensin ReceptorIBA 08/2021
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 08/2021
1	AVE 0991IBA 08/2021
1	compound 21IBA 08/2021
1	AngiotensinsIBA 08/2021
1	Therapeutic UsesIBA 10/2017
1	N-Methylaspartate (NMDA)IBA 08/2015
1	Glutamic Acid (Glutamate)FDA Link 08/2015
1	2,4-dinitrofluorobenzene sulfonic acidIBA 06/2013
1	DinitrobenzenesIBA 06/2013
1	Erythropoietin FDA Link 06/2013
1	Sulfonic AcidsIBA 06/2013
1	Hyaluronic Acid (Hyaluronan)IBA 12/2012
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 12/2012
1	Infliximab (Remicade)FDA Link 01/2012
1	IvabradineIBA 01/2012
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2011
1	PD 123319IBA 12/2011
1	Angiotensin Receptor AntagonistsIBA 12/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2006
1	AnthracyclinesIBA 04/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2006
1	Endothelins (Endothelin)IBA 02/2006
1	cyclo(Trp-Asp-Pro-Val-Leu)IBA 02/2006
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2006
1	Free Radical ScavengersIBA 01/2006
1	Oxygen (Dioxygen)IBA 08/2004
1	Membrane LipidsIBA 11/2003
1	Amikacin (A.M.K)FDA LinkGeneric 09/2003
1	Cisplatin (Platino)FDA LinkGeneric 10/2002

Therapy/Procedure

2	Therapeutics 08/2004 - 04/2002
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 08/2021
1	Intravenous Infusions 08/2021
1	Transplantation 08/2021
1	Stents 01/2019
1	Intravesical Administration 12/2012
1	Drug Therapy (Chemotherapy) 04/2006
1	Infusion Pumps (Infusion Pump) 08/2004